Your browser doesn't support javascript.
loading
MicroRNA-21 is a novel promising target in cancer radiation therapy.
Liu, Jia; Zhu, Hongcheng; Yang, Xi; Ge, Yangyang; Zhang, Chi; Qin, Qin; Lu, Jing; Zhan, Liangliang; Cheng, Hongyan; Sun, Xinchen.
Afiliación
  • Liu J; Department of Radiation Oncology, The First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Rd, Nanjing, 210029, China.
Tumour Biol ; 35(5): 3975-9, 2014 May.
Article en En | MEDLINE | ID: mdl-24446181
ABSTRACT
MicroRNAs (miRNAs) represent an important nonprotein part of the human genome in tumor biology. Among the several types of miRNAs, microRNA-21 (miR-21) is dysregulated in several types of cancer and plays a key role in carcinogenesis, recurrence, and metastasis. Thus, it can be a potential target for cancer therapy including radiation therapy. In this review, we focus on miR-21, which has been identified in human cancer tissues, to suggest reasonable strategies for future research. miR-21 may have an influence on cell cycle, DNA damage repair, apoptosis, autophagy, and hypoxia of cancer during irradiation. We review the use of miR-21 in cancer radiation therapy and describe the known functions and possible underlying molecular mechanisms of miR-21 in radiosensitivity and radioresistance. Furthermore, the current and potential future applications of miR-21 in cancer radiation therapy are also discussed.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias Límite: Humans Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias Límite: Humans Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: China